FdaApplication

ANDA 065337

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCHARTWELL RX SCIENCES LLC
application_typeANDA
approval_date2007-04-06

Products (2)

ProductActive ingredientStrengthDosage form
CEFDINIRCEFDINIR250MG/5MLFOR SUSPENSION;ORAL
CEFDINIRCEFDINIR125MG/5MLFOR SUSPENSION;ORAL

2 products